Oaktree Acquisition Corp. III Life Sciences CFO resigns; Thomas Sweeney appointed CFO

Oaktree Acquisition Corp. III Life Sciences

Courtney Conigliaro resigned as CFO effective June 3, 2025; resignation not due to any disagreements.
Board appointed Thomas Sweeney as CFO (principal accounting/financial officer) effective June 3, 2025.
Sweeney is a Managing Director at Oaktree Capital Management; will not receive compensation from the company.
Board confirmed Alvin Shih as chair of the audit committee.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Courtney Conigliaro

Chief Financial Officer

OACC · Oaktree Acquisition Corp. III Life Sciences

Effective: 2025-06-03
Successor: Thomas Sweeney
Filed: June 6, 2025, 7:59 PM ET

On June 3, 2025, Courtney Conigliaro notified the board of directors (the "Board") of Oaktree Acquisition Corp. III Life Sciences (the "Company") of her resignation as Chief Financial Officer of the Company.

Appointed

Thomas Sweeney

Chief Financial Officer

OACC · Oaktree Acquisition Corp. III Life Sciences

Effective: 2025-06-03
Filed: June 6, 2025, 7:59 PM ET

On June 3, 2025, the Board appointed Thomas Sweeney as new Chief Financial Officer (principal accounting and principal financial officer) of the Company, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Courtney Conigliaro resigned as Chief Financial Officer at Oaktree Acquisition Corp. III Life Sciences.

Action: resigned
Role: Chief Financial Officer

Exact text from the filing

On June 3, 2025, Courtney Conigliaro notified the board of directors (the "Board") of Oaktree Acquisition Corp. III Life Sciences (the "Company") of her resignation as Chief Financial Officer of the Company.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Thomas Sweeney was appointed as Chief Financial Officer at Oaktree Acquisition Corp. III Life Sciences.

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

On June 3, 2025, the Board appointed Thomas Sweeney as new Chief Financial Officer (principal accounting and principal financial officer) of the Company, effective immediately.

View on SEC.gov

Oaktree Acquisition Corp. III Life Sciences filing history →

Source: SEC EDGAR

accession 0001193125-25-137105

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.